OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 GrowthZacks Investment Research • 01/06/26
Here's Why You Should Retain OPKO Health Stock in Your Portfolio NowZacks Investment Research • 12/09/25
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/19/25
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/29/25
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial ResultsGlobeNewsWire • 10/29/25
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services BusinessesPRNewsWire • 09/15/25
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial ResultsGlobeNewsWire • 07/31/25
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity SymposiumGlobeNewsWire • 06/25/25
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/30/25
Down -24.31% in 4 Weeks, Here's Why OPKO Health (OPK) Looks Ripe for a TurnaroundZacks Investment Research • 04/22/25